Laserfiche WebLink
July 16, 2024 (Regular Meeting) <br />Page <br />patients, individuals with OUD and their friends and family <br />members, individuals at high risk of overdose, schools, <br />community navigators, outreach workers, persons being released <br />from jail or prison, or other members of the general public. <br />• Training and education regarding naloxone and other drugs that <br />treat overdoses for first responders, overdose patients, <br />patients taking opioids, families, schools, community support <br />groups, and other members of the general public. <br />6. Sixth strategy authorized <br />a. Name of strategy: Addiction Treatment for Incarcerated Persons <br />b. Strategy is included in Exhibit A <br />c. Item letter and/or number in Exhibit A to the MOA: Item 11 <br />d. Amount authorized for this strategy: $665,925 <br />e. Period of time during which expenditure may take place: <br />Start date of July 1, 2024 through end date of June 30, 2029 <br />f. Description of the program, project, or activity: <br />Funding will be utilized for the following: <br />• Provide evidence -informed treatment, including MAT, recovery <br />support, harm reduction, or other appropriate services to individuals <br />with OUD and any co-occurring SUD/MH conditions who are <br />incarcerated in jail or prison. <br />• Provide evidence -informed treatment, including MAT, recovery <br />support, harm reduction, or other appropriate services to individuals <br />with OUD and any co-occurring SUD/MH conditions who are leaving <br />jail or prison, have recently left jail or prison, are on probation or <br />parole, are under community corrections supervision, or are in re-entry <br />programs or facilities. <br />7. Seventh strategy authorized <br />a. Name of strategy: Reentry Programs <br />b. Strategy is included in Exhibit A <br />c. Item letter and/or number in Exhibit A to the MOA: Item 12 <br />d. Amount authorized for this strategy: $559,165 <br />e. Period of time during which expenditure may take place: <br />Start date of July 1, 2024 through end date of June 30, 2029 <br />f. Description of the program, project, or activity: Funding will be <br />utilized to provide evidence -informed treatment, including MAT, recovery <br />support, harm reduction, or other appropriate services to individuals <br />with OUD and any co-occurring SUD/MH conditions who are leaving jail or <br />prison, have recently left jail or prison, are on probation or parole, <br />are under community corrections supervision, or are in re-entry programs <br />or facilities. <br />8. Eighth strategy authorized <br />a. Name of strategy: Connect People Who Need Help to the Help They Need <br />b. Strategy is included in Exhibit B <br />c. Item letter and/or number in Exhibit B to the MOA: Item C <br />d. Amount authorized for this strategy: $702,748 <br />e. Period of time during which expenditure may take place: <br />Start date of July 1, 2024 through end date of June 30, 2029 <br />f. Description of the program, project, or activity: Funding will be used <br />to provide counseling, peer -support, recovery case management and <br />residential treatment with access to medications for those who need it to <br />persons with OUD and any co-occurring SUD/MH conditions. <br />9. Ninth strategy authorized <br />a. Name of strategy: Address the Needs of Pregnant or Parenting Women and <br />their Families <br />b. Strategy is included in Exhibit B <br />c. Item letter and/or number in Exhibit B to the MOA: Item E <br />d. Amount authorized for this strategy: $1,840,375 <br />e. Period of time during which expenditure may take place: <br />Start date of July 1, 2024 through end date of June 30, 2029 <br />f. Description of the program, project, or activity: <br />Funding will be utilized for the following: <br />• Support evidence -based or evidence -informed treatment, including <br />MAT, recovery services and supports, and prevention services for <br />pregnant women - or women who could become pregnant - who have <br />OUD and any co-occurring SUD/MH conditions, and other measures <br />to educate and provide support to families affected by Neonatal <br />Abstinence Syndrome <br />• Provide enhanced support for children and family members <br />suffering trauma as a result of addiction in the family and offer <br />Page 17 <br />